4
Changes in Ownership
4D Molecular Therapeutics, Inc. Filed Acc 0001193125-25-326851
Chief Legal Officer sold 1,635 shares at $10.90 ($17,822)
- Chief Legal Officer acquired 1,635 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bizily Scott · Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-16 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,635 | $4.14 | $6,769 | 5,229 | D |
| 2025-12-16 | Sale : show line 2 in the form 10b5-1 | −1,635 | $10.90 | $17,822 | 3,594 | D |
| Open-market sales · 1,635 sh · avg $10.90 · $17,822 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-16 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −1,635 | 73,595 | D |
Loading xslF345X05/ownership.xml…